Medtronic (Minneapolis) reported the start of the global launch of the MiniMed 640G System, the next breakthrough toward an artificial pancreas. With the introduction of Medtronic's exclusive SmartGuard technology, MiniMed 640G is designed to help people with diabetes achieve better glucose control through advanced protection from hypoglycemia. The system both automatically suspends insulin delivery when sensor glucose levels are predicted to approach a low limit and resume insulin delivery once sensor glucose levels recover. Read More
